BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16711505)

  • 1. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections].
    Pajares A; Larrea L
    Rev Esp Anestesiol Reanim; 2006 Apr; 53(4):266-7; author reply 268. PubMed ID: 16711505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Gielen-Wijffels SE; van Mook WN; Ramsay G
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):419. PubMed ID: 12661464
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII in the management of massive obstetric bleeding.
    Palomino MA; Chaparro MJ; de Elvira MJ; Curiel EB
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):226-7. PubMed ID: 16575264
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
    Dell'Utri D; Passariello M
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):570-2. PubMed ID: 16884992
    [No Abstract]   [Full Text] [Related]  

  • 6. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
    Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
    Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
    Hirasaki Y; Suematsu Y; Yasuda T; Tajima K
    Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application of recombinant activated factor VII in gynecological intervention (case report)].
    Nacheva A; Gateva Zh; Atanasova V
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():3-5. PubMed ID: 15673003
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C; Lucía JF
    Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
    El Kinge AR; Mahfouz RA; Shamseddine AI; Taher AT
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):577-9. PubMed ID: 17762536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
    Silver DA; D'Ambra MN
    Crit Care Med; 2007 Jul; 35(7):1782-3. PubMed ID: 17581365
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of recombinant FVIIa as treatment for abdominal bleeding in acquired hemophilia.
    Makris M; Hampton KK; Preston EE
    Am J Hematol; 2001 Jan; 66(1):67-8. PubMed ID: 11426500
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activated recombinant factor VII for bleeding after a kidney transplant].
    Vidal MA; Sebastianes C; Eizaga R; Martínez E; Torres LM
    Rev Esp Anestesiol Reanim; 2005 Dec; 52(10):638-9. PubMed ID: 16435622
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
    J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa reduces bleeding risk in patients on platelet aggregation inhibitors immediately prior to renal transplantation--a retrospective analysis.
    Loertzer H; Soukup J; Fornara P
    Urol Int; 2007; 78(2):135-9. PubMed ID: 17293653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of severe sphincterotomy bleeding with recombinant activated factor VII.
    Garrido-Serrano A
    Gastrointest Endosc; 2012 Oct; 76(4):925-6. PubMed ID: 22985655
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report.
    Marson F; Farnia A; Callegher L; Casagrande L; Surdu M; Sarpellon M
    Minerva Anestesiol; 2006; 72(7-8):675-82. PubMed ID: 16865086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation.
    Gielen-Wijffels SE; van Mook WN; van der Geest S; Ramsay G
    Intensive Care Med; 2004 Jun; 30(6):1232-4. PubMed ID: 14985956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Verrijckt A; Proulx F; Morneau S; Vobecky S
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1812-3. PubMed ID: 15173742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.